Product Information
OXYBUTYNIN 5 MG TABLET is a generic product labeled by Upsher-Smith Laboratories LLC, priced at $0.0473 per EA under NDC 00832003801. Its NADAC has been published 402 times since Dec 12, 2018.
FDA first approved this application on Jul 31, 1996. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
5 mg/1
Manufacturer
Upsher-Smith Laboratories LLCNDC
00832003801
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
OXYBUTYNIN CHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA074625FDA Approved
7/31/1996
TE Code
AB
On Market Since
11/7/2011
Pharmacological Classes
Price Statistics
The NADAC for OXYBUTYNIN 5 MG TABLET has been published 402 times since Dec 12, 2018, and over the history we have for it it has declined 72.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0473 per EA |
|---|---|
| All-time high | $0.1874 (Jul 10, 2019) |
| All-time low | $0.0448 (Nov 20, 2024) |
| 52-week high | $0.0498 |
| 52-week low | $0.0455 |
| Median price | $0.0707 |
| Average price | $0.0816 |
| Largest weekly change | -28.1% (Apr 17, 2024) |
| Weeks tracked | 402 |
| Tracking since | Dec 12, 2018 |
Generic Alternatives
The matcher finds 14 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of OXYBUTYNIN 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for OXYBUTYNIN 5 MG TABLET, manufactured by Upsher-Smith Laboratories LLC, is $0.0473 per EA (NDC 00832003801), effective Aug 19, 2026.
How has the price of OXYBUTYNIN 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for OXYBUTYNIN 5 MG TABLET has declined 72.7%. It has been tracked across 402 weekly CMS publications since Dec 12, 2018.
What are the highest and lowest recorded NADAC prices for OXYBUTYNIN 5 MG TABLET?
Since Dec 12, 2018, the NADAC for OXYBUTYNIN 5 MG TABLET has ranged from a low of $0.0448 (Nov 20, 2024) to a high of $0.1874 (Jul 10, 2019), with a median of $0.0707 per EA.
Are there cheaper alternatives to OXYBUTYNIN 5 MG TABLET?
14 manufacturers publish a NADAC-priced product with the same active ingredient and strength as OXYBUTYNIN 5 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures OXYBUTYNIN 5 MG TABLET?
OXYBUTYNIN 5 MG TABLET (NDC 00832003801) is labeled by Upsher-Smith Laboratories LLC, and CMS classifies it as a generic product.